Immunosuppression is now established as a beneficial approach but balancing risk and benefit is vital, especially for powerful approaches such as autologous stem cell transplantation. PubMed, Clin Med, 2015 Dec;15 Suppl 6:s58-63. (Also see Immunosuppressants and Stem Cell (Bone Marrow) Transplantation)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.